European Commission Dangles Conditional Approval Reprieve For PTC Therapeutics’ Translarna

 
• By Francesca Bruce

Scientific questions from member state experts and a recent court ruling on impartiality in the drug approval process prompted the European Commission to query the EMA’s negative opinion on PTC’s Translarna.

Bright horizon
A Brighter future for PTC's Translarna is possible after the European Commission has returned CHMP negative opinion • Source: Shutterstock

More from Europe

More from Geography